NEW

Lazurite a Reseller of LG Surgical Monitors

Medical device and technology company Lazurite Holdings LLC announced that it is working with LG Electronics USA as a reseller of LG’s high-performance surgical display monitors. “We’re delighted to announce that we are working with LG Electronics USA as a reseller of...

Lazurite, Minnetronix Medical Make New Wireless Surgical Camera a Reality

Lazurite and Minnetronix Medical have announced that the ArthroFree Wireless Surgical Camera System has achieved its final major milestone on the way to market: its first successful human use and the completion of its transfer to manufacturing. ArthroFree is the first...

Henry Schein Medical Helps Amplify Value of ASCs

Henry Schein Medical, the U.S. medical business of Henry Schein Inc., is helping to amplify the value ambulatory surgery centers (ASCs) bring to patients, providers and the health care ecosystem overall. The company recently featured key learnings and viewpoints from...

Encompass Presents New Patient Warming Blanket

Encompass Group LLC is showcasing Nova – the patented next generation patient warming blanket at The Georgia Council of perioperative Registered Nurses conference. “Years of research and development have led us to this innovative patient warming system,” says Michelle...

Joint Commission Issues Statement on Standards Review

The Joint Commission President and Chief Executive Officer Jonathan B. Perlin, MD, Ph.D., MSHA, MACP, FACMI, shared the following information on September 13, 2022.

Today we announced the beginning of a review of all Joint Commission “above-and-beyond” requirements, those that go beyond the Centers for Medicare & Medicaid Services (CMS) Conditions of Participation (CoPs) and are not on crosswalks to the CoPs.

During the COVID-19 public health emergency (PHE), CMS put many requirements on hold. As the PHE nears its end, CMS has been reviewing the waived requirements to determine whether some should be permanently retired. The Joint Commission will similarly address the necessity of our own unique requirements.

Specifically, we will review each requirement to answer:

  • Does the requirement still address an important quality and safety issue?
  • Is the requirement redundant?
  • Are the time and resources needed to comply with the requirement commensurate with the estimated benefit to patient care and health outcomes?

In addition to a direct review of each requirement, we will conduct quantitative analyses of scoring patterns and tests for redundancy. Where necessary, we also will conduct literature and field reviews and engage experts within the field.

American health care still has a long way to go to fully recover from COVID-19 and to reach a new equilibrium – especially as we are now witnessing secondary effects from the pandemic. At The Joint Commission, we are committed to working with health care organizations and other stakeholders to help address the many challenges health care is facing, as well as to making our own requirements as efficient and impactful on patient safety and quality as possible.

For more information, visit jointcommission.org.

Previous

Next

Submit a Comment

Your email address will not be published.

X